Liver mitochondrial dysfunction is reverted by insulin-like growth factor II (IGF-II) in aging rats

Journal of Translational Medicine

Volumn 9, Issue 1, 2011, Pages

  Garcia Fernandez, Maria ^a   Sierra, Inma ^b   Puche, Juan E ^b   Guerra, Lucia ^b   Castilla Cortazar, Inma ^b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATRACTYLOSIDE; CASPASE 3; CASPASE 9; CYTOCHROME C OXIDASE; FREE RADICAL; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; RECOMBINANT SOMATOMEDIN B; ANTIOXIDANT; HYDROGEN PEROXIDE; PROTON; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; SOMATOMEDIN B;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; LIPID OXIDATION; LIVER HOMOGENATE; LIVER MITOCHONDRION; LOW DRUG DOSE; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NONHUMAN; NUCLEOTIDE METABOLISM; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PROTEIN EXPRESSION; PROTON TRANSPORT; RAT; TREATMENT DURATION; ANIMAL; ENZYMOLOGY; HUMAN; METABOLISM; WISTAR RAT;

AGING; ANIMALS; ANTIOXIDANTS; ATP SYNTHETASE COMPLEXES; ATRACTYLOSIDE; CASPASE 3; CASPASE 9; ELECTRON TRANSPORT COMPLEX IV; HUMANS; HYDROGEN PEROXIDE; INSULIN-LIKE GROWTH FACTOR II; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, LIVER; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PROTONS; RATS; RATS, WISTAR;

EID: 79960654127     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-123     Document Type: Article

References (36)

1. Hoffman AR, Pyka G, Lieberman SA, Ceda GP, Marcus R. The sompatopause. Growth hormone and somatomedins during lifespan 1993, 265-274. New York: Springer-Verlag.
2. Ceda GP, Dall'Aglio E, Maggio M, Lauretani F, Bandinelli S, Falzoi C, Grimaldi W, Ceresini G, Corradi F, Ferrucci L, Valenti G, Hoffman AR. Clinical implications of the reduced activity of the GH-IGF-I axis in older men. J Endocrinol Invest 2005, 28:96-100.
3. Melling TR, Nylen ES. Growth hormone deficiency in adults: a review. Am J Med Sci 1996, 311:153-166. 10.1097/00000441-199604000-00001, 8602643.
4. García-Fernández M, Delgado G, Puche JE, González-Barón S, Castilla-Cortázar I. Low doses of insulin-like growth factor I improve insulin resistance, lipid metabolism, and oxidative damage in aging rats. Endocrinology 2008, 149(5):2433-2442. 10.1210/en.2007-1190, 18187555.
5. Puche JE, García-Fernández M, Muntané J, Rioja J, González-Barón S, Castilla Cortazar I. Low doses of insulin-like growth factor-I induce mitochondrial protection in aging rats. Endocrinology 2008, 149(5):2620-2627. 10.1210/en.2007-1563, 18276748.
6. Castilla-Cortázar I, García-Fernández M, Sierra I, Puche JE, Delgado G, Guerra L, González-Barón S. Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging rats. Journal of Translational Medicine
7. Kowaltowski AJ, Vercesi E. Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med 1999, 26:463-471. 10.1016/S0891-5849(98)00216-0, 9895239.
8. Cardoso SM, Pereira C, Oliveira CR. Mitochondrial function is differentially affected upon oxidative stress. Free Radic Biol Med 1999, 26:3-13. 10.1016/S0891-5849(98)00205-6, 9890635.
9. Bras M, Queenan B, Susin SA. Programmed cell death via mitochondria: different modes of dying. Biochemistry (Mosc) 2005, 70:231-239.
10. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999, 68:383-424. 10.1146/annurev.biochem.68.1.383, 10872455.
11. Brand MD, Pakay JL, Ocloo A, Kokoszka J, Wallace DC, Brookes PS, Cornwall EJ. The basal proton conductance of mitochondria depends on adenine nucleotide translocase content. Biochem J 2005, 392(Pt 2):353-362. 1316271, 16076285.
12. O'Connor JE, Vargas JL, Kimler BF, Hernandez-Yago J, Grisolia S. Use of rhodamine 123 to investigate alterations in mitochondrial activity in isolated mouse liver mitochondria. Biochem Biophys Res Commun 1988, 151:568-573. 10.1016/0006-291X(88)90632-8, 3348796.
13. Brand MD. The proton leak across the mitochondrial inner membrane. Biochim Biophys Acta 1990, 1018:128-133. 10.1016/0005-2728(90)90232-S, 2393654.
14. Brand MD. Measurement of mitochondrial proton motive force. A practical approach 1995, 39-62. Oxford University Press.
15. Monemdjou S, Kozak LP, Harper ME. Mitochondrial proton leak in brown adipose tissue mitochondria of Ucp1-deficient mice is GDP insensitive. Am J Physiol 1999, 276(6 Pt 1):1073-1082.
16. Cortese JD, Voglino AL, Hackenbrock CR. Persistence of cytochrome c binding to membranes at physiological mitochondrial intermembrane space ionic strength. Biochim Biophys Acta 1994, 1228:216-228.
17. National Academy of Sciences The guiding principles for research involving animals. 1991, Bethesda, MD: National Institutes of Health, National Academy of Sciences.
18. Vieira HL, Haouzi D, El Hamel C, Jacotot E, Belzacq AS, Brenner C, Kroemer G. Permeabilization of the mitochondrial inner membrane during apoptosis: impact of the adenine nucleotide translocator. Cell Death Differ 2000, 7:1146-1154. 10.1038/sj.cdd.4400778, 11175251.
19. Halestrap AP, Woodfield KY, Connern CP. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem 1997, 272:3346-3354. 10.1074/jbc.272.6.3346, 9013575.
20. Arab K, Steghens JP. Plasma lipid hydroperoxides measurement by an automated xylenol orange method. Anal Biochem 2004, 325:158-163. 10.1016/j.ab.2003.10.022, 14715297.
21. Miller NJ, Rice-Evans C, Davies MJ. A new method for measuring antioxidant activity. Biochem Soc Trans 1993, 21:95S.
22. Voss P, Siems W. Clinical oxidation parameters of aging. Free Radic Res 2006, 40:1339-1349. 10.1080/10715760600953859, 17090423.
23. Mirpuri E, Garcia-Trevijano ER, Castilla-Cortazar I, Berasain C, Quiroga J, Rodriguez-Ortigosa C, Mato JM, Prieto J, Avila MA. Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I. Int J Biochem Cell Biol 2002, 34:242-252. 10.1016/S1357-2725(01)00123-6, 11849991.
24. Yamamura T, Otani H, Nakao Y, Hattori R, Osako M, Imamura H. IGF-I differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart. Am J Physiol Heart Circ Physiol 2001, 280:1191-1200.
25. Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 2003, 195:158-167. 10.1002/jcp.10254, 12652643.
26. Kondo T, Kitano T, Iwai K, Watanabe M, Taguchi Y, Yabu T, Umehara H, Domae N, Uchiyama T, Okazaki T. Control of ceramide-induced apoptosis by IGF-1: involvement of PI-3 kinase, caspase-3 and catalase. Cell Death Differ 2002, 9:682-692. 10.1038/sj.cdd.4401019, 12032677.
27. Ness JK, Scaduto RC, Wood TL. IGF-I prevents glutamate-mediated bax translocation and cytochrome c release in O4+ oligodendrocyte progenitors. Glia 2004, 46:183-94. 10.1002/glia.10360, 15042585.
28. Sonntag WE, Bennett C, Ingram R, Donahue A, Ingraham J, Chen H, Moore T, Brunso-Bechtold JK, Riddle D. Growth hormone and IGF-I modulate local cerebral glucose utilization and ATP levels in a model of adult-onset growth hormone deficiency. Am J Physiol Endocrinol Metab 2006, 291(3):604-610.
29. Trejo JL, Carro E, Lopez-Lopez C, Torres-Aleman I. Role of serum insulin-like growth factor I in mammalian brain aging. Growth Horm IGF Res 2004, 14(Suppl A):S39-43.
30. Tong M, Dong M, de la Monte SM. Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. J Alzheimers Dis 2009, 16(3):585-599. 2852260, 19276553.
31. Syroid DE, Zorick TS, Arbet-Engels C, Kilpatrick TJ, Eckhart W, Lemke G. A role for insulin-like growth factor-I in the regulation of Schwann cell survival. J Neurosci 1999, 19:2059-2068.
32. Liang G, Cline GW, Macica CM. IGF-1 stimulates de novo fatty acid biosynthesis by Schwann cells during myelination. Glia 2007, 55:632-641. 10.1002/glia.20496, 17299765.
33. Fernandez S, Fernandez AM, Lopez-Lopez C, Torres-Aleman I. Emerging roles of insulin-like growth factor-I in the adult brain. Growth Horm IGF Res 2007, 17(2):89-95. 10.1016/j.ghir.2007.01.006, 17317256.
34. Llorens-Martín M, Torres-Alemán I, Trejo JL. Mechanisms mediating brain plasticity: IGF1 and adult hippocampal neurogenesis. Neuroscientist 2009, 15(2):134-48. 10.1177/1073858408331371, 19307421.
35. Sullivan KA, Kim B, Feldman EL. Insulin-like growth factors in the peripheral nervous system. Endocrinology 2008, 149(12):5963-71. 10.1210/en.2008-1020, 2613061, 18719018.
36. Chen DY, Stern SA, Garcia-Osta A, Saunier-Rebori B, Pollonini G, Bambah-Mukku D, Blitzer RD, Alberini CM. A critical role for IGF-II in memory consolidation and enhancement. Nature 2011, 27;469(7331):491-7.